IITRI

United States Founded: 1936 • Age: 90 yrs Acquired By Alion Science
Bioanalytical services are provided for research and development applications.
Annual revenue - Latest available
Total funding - 4 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 4 Services tracked
Competitors 11 Brand Intelligence

About IITRI

IITRI is a company based in United States founded in 1936 was acquired by Alion Science in December 2002. IITRI offers products and services including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services. IITRI operates in a competitive market with competitors including Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.

  • Headquarter United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Iit Research Institute
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.82 M (USD), Grant

    Dec 14, 2010

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Alion Science

    (Dec 01, 2002)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of IITRI

IITRI offers a comprehensive portfolio of products and services, including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.

Primary

Preclinical toxicology evaluation for drug safety and regulatory compliance.

Development of vaccines and therapeutics against pathogens.

Studies on inhaled drugs and aerosol challenges for safety.

Assays for immunogenicity and cellular responses in trials.

People of IITRI

Headcount 50-200
Employee Profiles 12
Employee Profiles
People
Israr Ahmad
Senior Toxicologist
People
Larry N.
Project Financial Analyst
People
Mary Smeaton
HR Manager
People
Patti Paas
Senior Human Resources Associate

Unlock access to complete

Funding Insights of IITRI

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $1.8M
  • First Round

    (05 Jul 2007)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2010 Amount Grant - IITRI Valuation

investors

HHS
May, 2010 Amount Grant - IITRI Valuation

investors

HHS
Aug, 2008 Amount Grant - IITRI Valuation

investors

HHS

Investors in IITRI

IITRI has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Alion Science.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Technology solutions are provided to U.S. federal government agencies.
Founded Year Domain Location

Investments & Acquisitions by IITRI

Investments

Financial Statements - IITRI

Iitri Comparisons

+
Add Comparison
Available on Premium

Competitors of IITRI

IITRI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microfluidics and mass spectrometry products are provided for clinical research.
domain founded_year HQ Location
Large-molecule bioanalysis is provided for biologics and biosimilars development.
domain founded_year HQ Location
Analytical and quality assurance services are provided for diverse industries.
domain founded_year HQ Location
Bioanalytical assays for drug development are developed and validated.
domain founded_year HQ Location
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
domain founded_year HQ Location
Provider of clinical trial and clinical development on bioanalytical services

Latest news on Iitri

Frequently Asked Questions about IITRI

IITRI was founded in 1936 and raised its 1st funding round 71 years after it was founded.

IITRI is headquartered in United States.

The company was founded in 1936 in the United States as a provider of bioanalytical services. Operations are centered in the biotechnology sector, where analytical testing and data support are delivered to clients in pharmaceuticals and life sciences. Services encompass bioanalytical methods for drug discovery and validation, conducted through established laboratory facilities. The domain iitri.org serves as the primary online platform for information and outreach.

IITRI's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

IITRI offers Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.

IITRI has 2 investors. Key investors include HHS, and Alion Science.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available